ABBOTT LABORATORIES — Director's Dealing 2005

Feb 23, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-02-18

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-02-18	Common shares without par value	A	9300	$46.34	Acquired	46368	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-02-18	Option (right to buy)	$46.34	A	63800	Acquired	2015-02-17	common shares (63800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	38550	Indirect
Common shares without par value	14494	Indirect
Common shares without par value	838	Indirect

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2005.

F4: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in a transaction exempt from Section 16 under 16(a)-11.

F5: Reporting person disclaims beneficial ownership of all securities held by his son.

F6: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08.